• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Argos Therapeutics Inc

+ Add to Watchlist

ARGS:US

10.2000 USD 0.8400 8.97%

As of 17:20:00 ET on 04/17/2014.

Snapshot for Argos Therapeutics Inc (ARGS)

Open: 9.6000 Day's Range: 9.6000 - 10.5502 Volume: 89,522
Previous Close: 9.3600 52wk Range: 7.9700 - 13.7400 1-Yr Rtn: -

Stock Chart for ARGS

No chart data available.
  • ARGS:US 10.2000
  • 1D
  • 1M
  • 1Y
9.3600
Interactive ARGS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ARGS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.9400
Est. PEG Ratio -
Market Cap (M USD) 202.24
Shares Outstanding (M) 19.65
30 Day Average Volume 82,145
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ARGS

No data available

Company Profile & Key Executives for ARGS

Argos Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform.

Hubert BirnerChairmanJeffrey D AbbeyPresident/CEO
Frederick M MiesowiczVP:Manufacturing/COOCharles A NicoletteVP:Research & Dev/CSO
More Company Profile & Key Executives for ARGS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil